Document is current
Any future updates will be listed below
-
Authors
Bulik, Cynthia M.
Micali, Nadia
MacDermod, Casey M.
Qi, Baiyu
Munn-Chernoff, Melissa A.
Thornton, Laura M.
White, Jennifer
Dinkler, Lisa
Pisetsky, Emily M.
Johnson, Jessica
Devine, Katelin R.
Ortiz, Shelby N.
Silverman, Ava E.
Berthold, Natasha
Dumain, Alexis
Guintivano, Jerry
Halvorsen, Matthew
Crowley, James J.
-
Funding
Funding for this research was provided by:
National Institute of Mental Health (R56MH129437, R56MH129437, R56MH129437, R56MH129437, R56MH129437)
Karolinska Institute
- License Information
-
More Information
Article History
Received: 19 July 2023
Accepted: 9 October 2023
First Online: 21 November 2023
Declarations
:
: ARFID-GEN was approved by the University of North Carolina Biomedical Institutional Review Board (IRB) Protocol # 22–1524. Informed consent will be obtained from all participants and/or their legal guardian(s). Child assent will also be obtained. All methods were carried out in accordance with relevant guidelines and regulations.
: Not applicable.
: CMB: Pearson (author, royalty recipient); Equip Health Inc. (Stakeholder Advisory Board). NM: receives an honorarium for services as Associate Editor for the European Eating Disorders Review. LD: reports speaker fees from Baxter Medical AB and Fresenius Kabi AB. CMM, BQ, MAM-C, LMT, JW, EMP, JJ, KRD, SNO, AES, NB, AD, JG, MH, JJC: no competing interests to declare.
